Linked Life Data

9393288

Source:http://linkedlifedata.com/resource/pubmed/id/9393288

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1997-12-23
pubmed:abstractText
The outcome of treatment for couples with male immunological infertility must be considered in conjunction with the risks, costs and time to success involved. Reversible factors should be treated. Steroid treatment is a good option but its failure in two-thirds of patients should add impetus to attempts to predict responders before or soon after starting treatment. The treatment options are not mutually exclusive [48]. The success of IUI may be enhanced further by new sperm preparation techniques. If severe immunological infertility exists or other infertility factors are present, IVF or ICSI may be considered from the outset.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0007-1331
pubmed:author
pubmed:issnType
Print
pubmed:volume
80
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
691-7
pubmed:dateRevised
2005-11-16
pubmed:meshHeading
pubmed:year
1997
pubmed:articleTitle
Antisperm antibodies and male subfertility.
pubmed:affiliation
Royal Marsden Hospital, London, UK.
pubmed:publicationType
Journal Article, Review